Patent application number | Description | Published |
20080304697 | APPARATUS AND METHODS FOR INTERFACING REPROGRAPHIC AND IMAGING SYSTEMS WITH MULTIPLE SET FINISHING DEVICES - Reprographic or imaging systems and methods issue a command to place multiple finishing devices into an alternating delivery mode such that consecutive sets are sent to different finishing devices, rather than to the same finishing device. | 12-11-2008 |
20090110411 | PRINTING SYSTEM AND METHOD FOR PURGING PRINT MEDIA - In a printing system having multiple document finishing assemblies, it is sometimes necessary to purge the system of print media which, as a result of a jam or other operational malfunction, remain within the printing system in an unfinished, unprinted, or otherwise undesirable condition. These “purge sheets” can be delivered to a separate purge tray provided at each document finishing assembly. A printing system having numerous document finishing assemblies will typically have a corresponding number of purge trays which must be cleared individually by an operator, which is inefficient and burdensome. The present disclosure provides a printing system and method which, in the event of a jam, consolidates purge sheets into a minimal number of purge trays. By minimizing the number of purge trays which must be cleared by an operator, efficiency gains and productivity increases can be realized. Additionally, the disclosed printing system is responsive to subsequent or multiple jams by diverting purge sheets to the minimal number of remaining purge trays. Exemplary embodiments of the disclosed purging algorithm are presented wherein purging is coordinated by the document finishing assemblies using a decentralized daisy-chain architecture, and wherein the purging is coordinated by a controller using a centralized architecture. | 04-30-2009 |
Patent application number | Description | Published |
20130227057 | SYSTEM FOR TRACKING DIFFUSION - A computer-implemented method tracks diffusion. The method includes receiving a tracking request from an initiating user to track diffusion of content located at a content address. A computer tracking system generates a first shortened content address for the content address, from which the content is provided to the initiating user. The method includes receiving content requests from one or more requesting users, and generating, for each requesting user, a unique subsequent shortened content address for the content address. Content is provided to each requesting user using the subsequent shortened content address generated for each requesting user respectively. Each content request from the requesting users is made using either the first shortened content address or one of the subsequent shortened content addresses. | 08-29-2013 |
20150156088 | SYSTEM FOR TRACKING DIFFUSION - A tracking system comprising a non-transitory computer readable storage medium having stored therein data representing instructions executable by a programmed processor for monitoring a database is provided. The storage medium includes instructions for storing a plurality of link identifiers in a database, each link identifier associated with a content address identifier and instructions for receiving a current shortened content address with an appended link identifier from a requesting user. The storage medium further includes instructions for determining a requested content address identifier associated with the current shortened content address and instructions for determining if the tracking system has previously received any previous shortened content address associated with the requested content address identifier from the requesting user. The storage medium also includes instructions for creating a new link identifier for the requesting user only when the tracking system has not previously received any previous shortened content address associated with the requested content address identifier from the requesting user. | 06-04-2015 |
20150163193 | SYSTEM FOR TRACKING DIFFUSION - A tracking system comprising a non-transitory computer readable storage medium having stored therein data representing instructions executable by a programmed processor is provided. The storage medium of the tracking system includes instructions for receiving a request for content from a device using a first shortened content address, the first shortened content address including a shortened content address base and a first link identifier. The storage medium further includes instructions for determining a content address identifier associated with the first shortened content address and instructions for searching the device for a cookie associated with the content address identifier, the cookie including a cookie link identifier. The storage medium also includes instructions for providing the content to the device using the first shortened content address when the cookie is found on the device and the cookie link identifier is the first link identifier and instructions for providing the content to the device using a second shortened content address when the cookie is found on the device and the cookie link identifier is not the first link identifier, the second shortened content address including the shortened content address base and the cookie link identifier. The storage medium further includes instructions for generating a new link identifier when the cookie is not found on the device and instructions for providing the content to the device using a third shortened content address when the cookie is not found on the device, the third shortened content address including the shortened content address base and the new link identifier. | 06-11-2015 |
20150295795 | SYSTEM FOR TRACKING DIFFUSION - A tracking system is provided comprising a non-transitory computer readable storage medium having stored therein data representing instructions executable by a programmed processor for monitoring a database. The storage medium comprises instructions for receiving a current shortened content address from a requesting user, the current shortened content address including a shortened content address base and an appended link identifier, and instructions for determining a content address associated with the current shortened content address. The storage medium further comprises instructions for storing the shortened content address base and the appended link identifier in a database and instructions for determining if the tracking system has previously received a request for a shortened content address associated with the content address from the requesting user. The storage medium also comprises instructions for generating a new link identifier when the system has not previously received a request for a shortened content address associated with the content address from the requesting user and instructions for recording a chain of relationships of appended link identifiers with any new link identifiers in the database | 10-15-2015 |
Patent application number | Description | Published |
20130073675 | MANAGING RELATED DIGITAL CONTENT - Aspects of the present disclosure relate to one or more configured computing systems identifying companion content and supplemental content for a base content. Companion content may include, for example, video adaptations of the base content. Supplemental content may include content referenced or related in subject matter to the base content. Information regarding companion content may be utilized to enable a user to interchangeably or synchronously present either a base content (e.g., an eBook or audio book) with the companion content (e.g., a movie adaptation). Information regarding supplemental content may be utilized to present the supplemental content during consumption of a base content, or to save supplemental content for later viewing. | 03-21-2013 |
20130074133 | MANAGING RELATED DIGITAL CONTENT - Aspects of the present disclosure relate to one or more configured computing systems identifying companion content and supplemental content for a base content. Companion content may include, for example, video adaptations of the base content. Supplemental content may include content referenced or related in subject matter to the base content. Information regarding companion content may be utilized to enable a user to interchangeably or synchronously present either a base content (e.g., an eBook or audio book) with the companion content (e.g., a movie adaptation). Information regarding supplemental content may be utilized to present the supplemental content during consumption of a base content, or to save supplemental content for later viewing. | 03-21-2013 |
20150261747 | SELECTING AND CONVEYING SUPPLEMENTAL CONTENT - Base items of content may be conveyed by a user computing device. These base items of content may be enhanced with enhancement content, such as sounds, songs, video clips, animations, images, multimedia content, and the like. Characteristics and enhancement objects may be identified in a portion of the base item of content, and enhancement content may be assigned to that portion automatically by a content enhancement service. In one embodiment, enhancement sounds or songs may be provided and conveyed to enhance an audiobook or electronic book. | 09-17-2015 |
Patent application number | Description | Published |
20130257871 | Content Customization - A content processing service may analyze an item of original content and identify several objects, attributes of those objects, and relationships between those objects present in the item of original content. The content processing service may also analyze a source graph, such as a social graph or supplemental graph, and identify several objects, attributes of those objects, and relationships between those objects present in the source graph. The content processing service may customize the item of original content by selecting an original object and selecting a source graph object. One or more of the attributes or relationships of the selected original object in the item of original content may be replaced by one or more of the attributes or relationships of the selected source graph object, thereby forming an item of modified content. | 10-03-2013 |
20130262127 | Content Customization - A content processing service may analyze an item of original content and identify several objects, attributes of those objects, and relationships between those objects present in the item of original content. The content processing service may also analyze a source graph, such as a social graph or supplemental graph, and identify several objects, attributes of those objects, and relationships between objects present in the source graph. The content processing service may customize the item of original content by selecting an original object and selecting a source graph object. One or more of the attributes or relationships of the selected original object in the item of original content may be replaced by one or more of the attributes or relationships of the selected source graph object. To customize items of audio content, audio content associated with the source graph object may replace audio content associated with the target graph object. | 10-03-2013 |
20140005814 | PACING CONTENT | 01-02-2014 |
20140122564 | MANAGING USE OF A SHARED CONTENT CONSUMPTION DEVICE - Features are disclosed for identifying multiple users contending for use of a shared media device with which to present a content item. Users may be detected by the shared media device or a management component, and each user may have previously begun and stopped consumption at a different point within the content item. When multiple users wish to consume the content, a component or module determines which presentation position to use, or creates a new presentation position for use. In cases in which not all users have begun consuming or wish to consume the same content item, a component or module determines which content item to present. | 05-01-2014 |
20150215382 | AUTOMATED TRANSITION OF CONTENT CONSUMPTION ACROSS DEVICES - Features are disclosed for transferring the presentation or playback of content from device to device. The content may include, but is not limited to, aural, video, and multimedia content. A personal device may be detected playing content. A current play position of the content can be obtained, and playback can be halted. The play position can be transferred to a media device wherein playback is automatically resumed. Additionally, the playing of content may be transferred between two or more media devices, for example in response to the movement of a user. Personal device movements and content operations may be monitored in order to determine improvements to the automatic transfer of content consumption from device to device. | 07-30-2015 |
Patent application number | Description | Published |
20160114037 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY - The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))). | 04-28-2016 |
20160115221 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY - The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))). | 04-28-2016 |
Patent application number | Description | Published |
20150225477 | Compositions for Selective Reduction of Circulating Bioactive Soluble TNF and Methods for Treating TNF-Mediated Disease - An isolated or synthetic antibody or ligand is provided that specifically binds to an epitope of a dissociated monomer of human TNF. Such binding disrupts assembly of the monomer into bioactive trimeric human sTNF. A pharmaceutical composition contains one or more antibodies or ligands: (a) an antibody or ligand that specifically binds the TNF monomer-specific epitope having the sequence PSDKPVAH or PSDKPVAHV, amino acids 8-15 or 8-16 of SEQ ID NO: 1; and (b) an antibody or ligand that specifically binds the TNF monomer-specific epitope having the sequence EPIYLGGVF, amino acids 116 to 124 of SEQ ID NO: 1. A combination of antibodies or ligands that bind or are reactive with (a) and/or (b) are useful in methods for treating a subject having a disease (e.g., rheumatoid arthritis, ankylosing spondylitis, juvenile rheumatoid arthritis, psoriatic arthritis, atherosclerosis, metabolic syndrome, Alzheimer's Disease, HIV, Type II diabetes) mediated by human TNF. These methods and compositions disrupt or reduce the in vivo assembly or reassembly of dissociated monomers of TNF into bioactive trimeric human sTNF. | 08-13-2015 |
20150225478 | Immunogenic and Prophylactic Compositions, Methods of Making Same, and Methods for Treating and Preventing TNF-Mediated Disease - An immunogenic composition comprises a peptide that induces in vivo TNF monomer-specific antibodies that bind an epitope of dissociated monomers of human TNF, the epitope being located wholly or partially within a TNF monomer-monomer interface region. Antibodies induced in vivo by this composition disrupt assembly or prevent re-assembly of the TNF monomers into bioactive trimeric human sTNF. The composition can comprise an additional peptide that induces in vivo TNF monomer-specific antibodies that bind another epitope of dissociated monomers of human TNF. Methods of making these immunogenic compositions are also described. Methods for treating a subject having a disease mediated by human TNF comprise administering a described immunogenic compositions which induces antibodies in a treated subject that disrupt or reduce the in vivo assembly or reassembly of dissociated monomers of TNF into bioactive trimeric human sTNF. These compositions and methods do not affect the structure or bioactivity of tmTNF or increase the treated subject's susceptibility to infection by an intracellular pathogen. | 08-13-2015 |
Patent application number | Description | Published |
20080200548 | N-Acetylcysteine Amide (Nac Amide) for Treatment of Oxidative Stress Associated with Infertility - An in vitro culture and/or fertilization medium containing N-acetylcysteine amide (NAC amide) reduces or prevents oxidative stress and free radical formation that contribute to the cellular damage and eventual demise of sperm, oocytes and embryos that are cultured, fertilized and maintained in vitro. The NAC amide-containing medium composition for in vitro culture and fertilization is suitable for use in the culture of oocytes, in the culture and development of early embryos, in the preparation or culture of sperm, and in the pre-treatment of oocytes or sperm. The NAC amide-containing composition supports the growth of viable embryos until blastocyst stage. | 08-21-2008 |
20080274888 | N-Acetylcysteine Amide (Nac Amide) for Enhancing Plant Resistance and Tolerance to Environmental Stress - The potent antioxidant N-acetylcysteine amide (NAC amide), or a physiologically acceptable derivative, salt, or ester thereof, is topically or exogenously applied to a plant, or part thereof, to reduce or prevent adverse reactions of plants and crops to environmental biotic and abiotic stresses, such as extremes of temperature, drought, humidity, frost, rain, as well as the presence or invasion of a variety of pests and pathogens. Such environmental stresses can result in oxidative stress and the correlated production (and buildup) of free radicals in plant cells, which damages plant cells and tissues and can lead to plant death. NAC amide reduces, prevents, alleviates, or otherwise counteracts such oxidative stress and free radical production, which adversely effect the overall growth and viability of the plant. | 11-06-2008 |
20090234011 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS - Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione. | 09-17-2009 |
20100120920 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS - Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione. | 05-13-2010 |
20100137441 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS - Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione. | 06-03-2010 |
20100137676 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR TREATMENT OF OXIDATIVE STRESS ASSOCIATED WITH INFERTILITY - An in vitro culture and/or fertilization medium containing N-acetylcysteine amide (NAC amide) reduces or prevents oxidative stress and free radical formation that contribute to the cellular damage and eventual demise of sperm, oocytes and embryos that are cultured, fertilized and maintained in vitro. The NAC amide-containing medium composition for in vitro culture and fertilization is suitable for use in the culture of oocytes, in the culture and development of early embryos, in the preparation or culture of sperm, and in the pre-treatment of oocytes or sperm. The NAC amide-containing composition supports the growth of viable embryos until blastocyst stage. | 06-03-2010 |
20140187640 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS - Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione. | 07-03-2014 |
20150038586 | USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF PENETRATING HEAD INJURY - This disclosure describes methods of use for N-acetylcysteine amide for the treatment of penetrating head injury. | 02-05-2015 |
20150133558 | USE OF N-ACETYLCYSTEINE AMIDE FOR DECREASING INTRACRANIAL PRESSURE - This disclosure describes methods of use for N-acetylcysteine amide for the treatment of penetrating head injury. | 05-14-2015 |
20150148423 | USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF DISEASE AND INJURY - This disclosure describes methods of use for N-acetylcysteine amide for the treatment of various disorders | 05-28-2015 |
Patent application number | Description | Published |
20120331496 | METHODS AND APPARATUS FOR PRESENTING SOCIAL NETWORK CONTENT IN CONJUNCTION WITH VIDEO CONTENT - Methods and apparatus for generating, distributing, and/or presenting social networking content in conjunction with video content are described. In accordance with various embodiments, social networking related information, e.g., comments, remarks and/or a twitter feed, are displayed in conjunction with the display of video to which the social networking information relates. The social networking related information may be displayed on the same or a different device from that which is used to display the video comments. In some embodiments, the social networking information, e.g., comments on a program, event or broadcast, are displayed on a personal computer or other device such as a mobile telephone, while video content is being viewed, e.g., on a television which is provided video content via a set top box. A knowledgeable moderator can review, supplement, add and delete comments in real time enhancing the overall social networking session. | 12-27-2012 |
Patent application number | Description | Published |
20090061448 | METHOD FOR IDENTIFYING OCULOSKELETAL DYSPLASIA IN DOGS - Provided are methods for identifying dogs as likely to be genetically normal, carriers of, or affected with Oculo-skeletal dysplasia (OSD) by determining the presence or absence of a drd2 COL9A2 mutation and/or a drd1 COL9A3 mutation. Also provided is a method for selective breeding of dogs and kits useful for carrying out the methods of the invention. | 03-05-2009 |
20090111976 | Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same - Tools and methods are provided for determining whether or not a dog is genetically normal, is a carrier of, or is affected with or predisposed to progressive rod-cone degeneration. The method is based on the detection of a transversion from G to A at position corresponding to nucleotide position 1298 of SEQ ID NO: 1. | 04-30-2009 |
20090176225 | DIAGNOSTIC TEST FOR COLLIE EYE ANOMALY - The invention relates to a method for identifying dogs which are genetically normal, heterozygous for, or homozygous for the mutation primarily responsible for Collie eye anomaly (CEA). The method comprises the steps of obtaining a biological sample from a dog and testing DNA in the biological sample for the presence or absence of a 7.8 kilobase deletion within chromosome 37 in which the CEA mutation is located. No deletion is indicative of a normal dog. A deletion on one allele of chromosome 37 is indicative of a dog that is heterozygous for the CEA mutation. A deletion in both alleles of chromosome 37 are indicative of a dog that is homozygous for the CEA mutation. Also provided is a kit for identifying a dog as normal, heterozygous for, or homozygous for the CEA mutation. | 07-09-2009 |
20100323349 | Identification of the Gene and Mutation Responsible for Progressive Rod-Cone Degeneration in Dog and a Method for Testing Same - Tools and methods are provided for determining whether or not a dog is genetically normal, is a carrier of, or is affected with or predisposed to progressive rod-cone degeneration. The method is based on the detection of a transversion from G to A at position corresponding to nucleotide position 1298 of SEQ ID NO: 1. | 12-23-2010 |
Patent application number | Description | Published |
20100169802 | Methods and Systems for Storing, Processing and Managing User Click-Stream Data - Methods and systems for enabling users to capture, store, and analyze attention data, particularly Internet website click-stream data. Captured, stored attention data may be used by the individual, or, through permissions, the data may be made available to other private and commercial users. The invention thus enables users to recognize both personal and potential commercial value from an electronic record of their attention. The invention includes not only the basic capture and store of attention data, but also the ability to process attention data in a variety of different manners. | 07-01-2010 |
20130231982 | METHODS AND SYSTEMS FOR USING MULTIPLE DATA SETS TO ANALYZE PERFORMANCE METRICS OF TARGETED COMPANIES - New and improved methods and systems for modeling the performance of selected company metrics. Multiple, nontraditional sets of objective data along with mathematical analytical techniques are used to provide transparency and visibility into company performance relating to the particular metrics. Company inflection points and changes in strategy may be identified. The performance of a company and/or the performance of a selected industry or industry sector may be analyzed. | 09-05-2013 |
20140297364 | METHODS AND SYSTEMS FOR USING MULTIPLE DATA SETS TO ANALYZE PERFORMANCE METRICS OF TARGETED COMPANIES - New and improved methods and systems for modeling the performance of selected company metrics. Multiple, non-traditional sets of objective data along with mathematical analytical techniques are used to provide transparency and visibility into company performance relating to the particular metrics. Company inflection points and changes in strategy may be identified. The performance of a company and/or the performance of a selected industry or industry sector may be analyzed. | 10-02-2014 |